Positioned for Record Profits! The Biotech You NEED to Watch!

Q1 and Q2 saw monumental revenues. Could Q3 be even bigger for this biotech stock?

BSEM is set to report third quarter results on November 12th. 2024 has been a record year with both Q1 and Q2 results blowing it out of the water. Is Q3 going to be as tremendous?

The biotech space staged a comeback in late 2023 and early 2024 as Big Pharma tapped into takeovers again. In mid-July biotech tech stocks even hit a two-year high. One biotech company with exciting developments that looks to be going underfollowed is BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care. The company is addressing two multi-billion dollar markets. According to Zacks, the average 12-month price target for BioStem Technologies, Inc. (BSEM) is $24.25! Why might Zack’s Small Cap Research be so bullish on BSEM with a $24.25 price target? Stellar Q2 financial results is one reason!

Now that BSEM is set to report third quarter results soon, could Zack’s SCR be ready to increase their price target yet again? Zack’s has said: “Investors are increasingly understanding our positive view of BSEM as the stock has experienced a rapid rise over the past year, but we believe the stock is still undervalued.” AND ON ANOTHER EXCITING FRONT THAT COULD SERVE AS A CATALYST FOR GROWTH IS THAT A NASDAQ LISTING COULD BE AROUND THE CORNER FOR THE COMPANY! BSEM recently announced that it has filed with the SEC to register its shares pursuant to the Securities Exchange Act of 1934, which is an important step in its plan to uplist to the Nasdaq stock exchange. BSEM on the NASDAQ would open up the stock to new investors, especially on the institutional front!

Discover more about BSEM and its superior products that are capturing major attention in the medical community and leading to record revenues for the company!

Important Notice and DISCLAIMER

To more fully understand any subscription, website, application, product, or other service (“Services”) including Financial Newsletter, please review our full disclaimer and other policies located at https://financialnewsletter.com/disclaimer/

Issuer-paid Advertisement. Sideways Frequency (or the “Company”) has paid or will pay Publisher up to five thousand dollars for marketing services including communicating information about the Company to the Public. This advertorial (“advertisement” or “Advertorial”) is part of those issuer-paid marketing services. The marketing services are anticipated to last one month, however, the term of the services could be extended or it could be terminated earlier. As a result of this advertisement and other marketing efforts, Publisher also may receive advertising revenue from new advertisers and collect email addresses from readers that it may be able to monetize. As of the date of this advertisement, Publisher holds no securities of the Company and does not intend to purchase any securities during the Term. This advertisement and other marketing efforts may increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of (OTC:BSEM), increased trading volume, and possibly an increased share price of the (OTC:BSEM) securities, which may or may not be temporary and decrease once the marketing services have ended.

For Educational and Information Purposes Only; Not Investment Advice. This advertisement is for educational and informational purposes only. All material information contained in this advertisement is based on information generally available to the public, which public information is believed to be reliable and accurate. Nevertheless, Publisher cannot guarantee the accuracy or completeness of the information. This advertisement does not purport to be a complete analysis of this Company or any company’s financial position. This advertisement or any statements made in it is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular individual. The statements made in this advertisement should NOT be relied upon for purposes of investing in the Company that is the subject of the Advertorial or any other companies mentioned in this Advertorial, nor should they be construed as a personalized recommendation to you to buy, sell, or hold any position in any security mentioned in this Advertorial or in any other security or strategy. It is strongly recommended that you consult a licensed or registered professional before making any investment decision.

SUBSTANTIAL RISK INVOLVED. Any individual who chooses to invest in the securities of the Company profiled in the Advertorial or any securities of the companies mentioned in this advertisement should do so with caution. Although this advertisement focuses on the positive features of the Company profiled and its securities, you must keep in mind that investing or transacting in these or any securities involves substantial risk; you may lose some, all, or possibly more than your original investment. Readers of this advertisement bear responsibility for their own investment research and decisions, and should use information from this Advertisement only as a starting point for doing additional independent research in order to allow individuals to form their own opinion regarding investments. It is easy to lose money investing or trading, and we recommend always seeking individual advice from a licensed or registered professional and educating yourself as much as possible before considering any investments.

Not an Investment Advisor or Registered Broker. Neither Publisher, nor any of their owners, employees or independent contractors is currently registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization.

SUBJECT OF SEC CONSENT ORDER. Publisher’s owner consented to the entry of an SEC Judgment whereby he agreed not to violate the securities laws and a permanent bar from participating in an offering of penny stock as defined by Rule 3a51-1 of the Securities Exchange Act of 1934.

USE OF FORWARD-LOOKING STATEMENTS. Certain statements made in this advertisement may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and 21E of the Exchange Act of 1934. Forward-looking statements often include words such as “believes,” “anticipates,” “estimates,” “expects,” “projects,” “intends,” or other similar expressions of future performance or conduct. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made and are not statements of historical fact. They involve many risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. There is no guarantee that past performance will be indicative of future results. Publisher does not undertake an obligation to update forward-looking statements in light of new information or future events. Readers can and should review all public SEC filings made by the Company profiled in the Advertorial here.

TRADEMARKS. All trademarks used in this advertisement are the property of their respective trademark holders and no endorsement by such owners of the contents of the advertisement is made or implied.